4//SEC Filing
Friedland Jeffrey 4
Accession 0001214659-18-002063
CIK 0001625288other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 7:13 PM ET
Size
8.9 KB
Accession
0001214659-18-002063
Insider Transaction Report
Form 4
Friedland Jeffrey
DirectorChief Executive Officer10% Owner
Transactions
- Disposition to Issuer
Common Stock
2018-03-08−1,166,667→ 833,333 total
Holdings
- 20,800(indirect: By LLC)
Class B Warrants (right to buy)
Exercise: $0.38From: 2017-11-29Exp: 2018-05-07→ Common Stock (20,800 underlying) - 228,800(indirect: By LLC)
Common Stock
- 20,800(indirect: By LLC)
Class C Warrants (right to buy)
Exercise: $0.50From: 2017-11-29Exp: 2018-07-14→ Common Stock (20,800 underlying) - 24,000,000(indirect: By Intiva USA Inc.)
Common Stock
Footnotes (1)
- [F1]Mr. Friedland resigned as an officer and director on March 8, 2018, thereby causing his unvested shares granted under the Company's Stock Incentive Plan to be forfeited and returned to the Company for cancellation.
Documents
Issuer
Intiva BioPharma Inc.
CIK 0001625288
Entity typeother
Related Parties
1- filerCIK 0001579962
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 7:13 PM ET
- Size
- 8.9 KB